EUVIMEDEUVIMED entdecken
Open Access

Azithromycin and moxifloxacin resistance determinants in Mycoplasma genitalium in Lleida, Spain

L Fraile García, J Aramburu Arnuelos, E López González, A Bellés-Bellés, A Muñoz Santa, E Sánchez Báscones, S Mormeneo Bayo, A Bernet Sánchez, I Prats Sánchez, A Cumplido Portillo, M García González

Revista Española de Quimioterapia · 2024

DOI: 10.37201/req/015.2024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista Española de Quimioterapia, 2024. Verfasst von L Fraile García und 10 weiteren Autor:innen. Beteiligte Einrichtung: Alba Bellés Bellés. Sección de Microbiología y Parasitología, Hospital Universitari Arnau de Vilanova. Avenida Rovira Roure 80, 25198. Lleida, Spain.…. Hauptthemen laut MEDLINE: Mycoplasma genitalium, Moxifloxacin, Azithromycin, Anti-Bacterial Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Mycoplasma genitalium (MG) is a microorganism related to sexually transmitted infections. Antibiotic resistance of MG leads to an increase in treatment failure rates and the persistence of the infection. The aim of this study was to describe the most frequent mutations associated with azithromycin and moxifloxacin resistance in our geographical area. Material and methods. A prospective study from May 2019 to May 2023 was performed. MG-positive samples were collected. Real-time PCRs (AllplexTM MG & AziR Assay and AllplexTM MG & MoxiR Assay, Seegene) were performed in MG positive samples to detect mutations in 23S rRNA V domain and parC gene.

Results

A 37.1% of samples presented resistance determinants to azithromycin and the most common mutation detected was A2059G (57.9%). Resistance to moxifloxacin was studied in 72 azithromycin-resistant samples and 36.1% showed mutations, being G248T the most prevalent (73.1%).

Conclusions

The resistance to different lines of treat ment suggests the need for a targeted therapy and the performing of a test of cure afterwards.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycoplasma genitaliumMoxifloxacinAzithromycinAnti-Bacterial AgentsDrug Resistance, BacterialMycoplasma InfectionsMutationSpainHumansProspective StudiesFemaleMaleMicrobial Sensitivity TestsRNA, Ribosomal, 23SAdultDNA Topoisomerase IV

Stichwörter der Autor:innen

Mycoplasma genitaliumazithromycinmoxifloxacinmutationresistance

Substanzen

MoxifloxacinAzithromycinAnti-Bacterial AgentsRNA, Ribosomal, 23SDNA Topoisomerase IV

Autor:innen und Institutionen

  • Alba Bellés Bellés. Sección de Microbiología y Parasitología, Hospital Universitari Arnau de Vilanova. Avenida Rovira Roure 80, 25198. Lleida, Spain. abelles.lleida.ics@gencat.cat.

Zitieren

APA

Fraile García, L., Aramburu Arnuelos, J., López González, E., Bellés-Bellés, A., Muñoz Santa, A., Sánchez Báscones, E., Mormeneo Bayo, S., Bernet Sánchez, A., Prats Sánchez, I., Cumplido Portillo, A., & García González, M. (2024). Azithromycin and moxifloxacin resistance determinants in Mycoplasma genitalium in Lleida, Spain. Revista Española de Quimioterapia. https://doi.org/10.37201/req/015.2024

Vancouver

Fraile García L, Aramburu Arnuelos J, López González E, Bellés-Bellés A, Muñoz Santa A, Sánchez Báscones E, et al. Azithromycin and moxifloxacin resistance determinants in Mycoplasma genitalium in Lleida, Spain. Revista Española de Quimioterapia. 2024. doi:10.37201/req/015.2024

BibTeX
@article{FraileGarca2024,
  author = {Fraile García, L and Aramburu Arnuelos, J and López González, E and Bellés-Bellés, A and Muñoz Santa, A and Sánchez Báscones, E and Mormeneo Bayo, S and Bernet Sánchez, A and Prats Sánchez, I and Cumplido Portillo, A and García González, M},
  title = {Azithromycin and moxifloxacin resistance determinants in Mycoplasma genitalium in Lleida, Spain},
  journal = {Revista Española de Quimioterapia},
  year = {2024},
  doi = {10.37201/req/015.2024}
}
Kostenlos starten →